FDA Investigator Joseph M Willems
Joseph M Willems has conducted inspections on 163 sites in 2 countries as of 24 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
163
Last Inspection Date:
24 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Mexico
FDA Investigators that have inspected at least one site in common with Joseph M Willems:
Adrienne J Goodrich Doctor,
Alex G Kalugin,
Alexandra B Pitkin,
Andrew E Kay,
Angel K Sandhu,
Angela D Wise,
Anh M Lac,
Anna J Vickrey,
Anna L Marroquin,
Anna L Viveros Hernandez,
Anthony E Guzman,
Aric M Sonnenschein,
Arturo De La Garza,
Ashar P Parikh,
Avery B Cromwell,
Barbara J Rincon,
Benny Y Gong,
Brandon Adcock,
Brenda K Alford,
Brian P Hendrickson,
Brian P Putz,
Brian R Henderson,
Brian R Yaun,
Carla J Lundi,
Carrie E Thrasher,
Cathleen A Carr Sharpe,
Cesar A Herrera,
Chloe Anne Leong,
Christine M Parmentier,
Christopher J Lee,
Cindy W Lewis,
Courtney R Bolton,
Cristina Resendiz Navarrete,
Daniel C Geffin,
Daniel J Gorski,
Daniel J Roberts,
Daniel Velasquez,
Darrin E Davis,
David A Laplante,
David Castillo,
David Y Hernandez,
Deborah K Richardson,
Dejon N Harris,
Donna Ltartaglino Besone,
Edna J Hidalgo,
Edward D Harris,
Elodie X Tong Lin,
Elva M Centeno,
Elva M Ibarra,
Emal Wahab,
Eric J Heinze,
Eric Maddox,
Eric W Anderson,
Erica Fernandez,
Erica L Nicoll,
Erica R Pomeroy,
Erin L Nagel,
Erin M Hale,
Estefania F Garber,
Estefania Fernandez,
Garciam,
Givensj,
Greg K Keshishyan,
Gulshan R Anand,
Helen J Hamaoka,
Herbert E Arden,
Humberto Z Gomez,
Ingrid A Zambrana,
Ismael Garibay,
James A Barreto,
James C Yee,
Jamie L Port,
Janice K Gardner,
Janice Wai,
Jazmine M Welcher,
Jeanmaire Hryshko,
Jeffrey W Shrifter, DPM,
Jennifer S King,
Joanne M Fukuda,
Jocelyn T Ramos,
John A Liu,
John Fox,
Jonathan M Mcbride,
Jonetta I Collins,
Joseph C Yen,
Joseph R Haynes,
Joseph Tibay,
Juan A Morales,
Julia Ventura,
Juliane Kjung Lau,
Justin M Runac,
Kacie M Crowther,
Karen D Phung,
Karen J Bak,
Karen L Robles,
Karen M Willis,
Karla J Gibler,
Kate L Allen,
Katherine E Jacobitz,
Kawshalya Pathiraja,
Kenneth G Klobus,
Keren Arkin,
Kevin T Gerrity,
Kimberlee A Ewing,
Kimberly L Anderson,
Kristen E Szenderski,
Lam,
Laura A Grumenfelder,
LCDR Jennifer H Rhyu,
Ligia M Cline,
Ligia M Sanders,
Lija V Fellows,
Lillian C Lopez,
Linda Linh N Adams,
Linda S Shook,
Lisa H Nakagawa,
Lopez,
Lorenzo F Edwards,
Lorraine N Williams,
LT Mark A Chen, MPH,
Lucila B Nwatu,
Macropolk,
Maridali Deleon Torres,
Mario R Velasquez,
Marissa J Chan,
Mark C Saale,
Mark E Baldwin,
Mark E Imsland,
Mark I Nakano,
Mary C Acton,
Mary C Wall,
Matthew A Walburger,
Mcgrewp,
Megan T Wright,
Michael D Garcia,
Michael D Kawalek,
Michael E Barta,
Michael S Call,
Michelle L Lopez,
Miguel Gmanzano Maldonado,
Myers,
Naveen B Walker,
Ngoc T Le,
Nicolas C Tolosa, III,
Nicole Yuen,
Nympha V Florendo,
Paola E Lathrop,
Peter E Baker,
Phillip J Sample,
Phung,
Quynh H Strandberg,
Rachel J Cantrell,
Randall F Albright,
Randall J Plunkett,
Randy L Elsberry,
Raymond Souweha,
Rebecca E Sulpacio,
Robert J Waldorf,
Roberta K Smith,
Robles,
Rocio Guzman Velazquez,
Rodrigo O Chipres,
Ronald P Boyce,
Rumany C Penn, PharmD,
Ryan J Borges,
Savannah E Samp,
Scott J Matsuda,
Seema S Singh,
Sergio Chavez (NMI),
Seyyida Saterfield,
Shane E Rainey,
Shane R Teeter,
Shannon R Hoehna,
Sondra R Davis,
Stephen G Mclane,
Steve P Yost,
Steven M Galvez,
Stuart W Russell,
Suzanne M Crotty,
Tanya E Malais,
Thanh M Andrews,
Thomas N Adjabeng,
Thomas W Gordon,
Timothy C Grome,
Tomanik'e C Banks,
Travis K Chapin,
Tristian E Strait,
Trusten J Robles,
Tuan D Tran,
Uttaniti Limchumroon (Tom),
Vi T Au,
Victoria Taylor,
Wenting Lei,
William J Foust,
William J Weis,
Zachary Ryan Harris
Joseph M Willems's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| November, 2018 | FDA 483 Response | ARO Pistachios, Inc. - Form 483R, 2018-12-03 |
| September, 2019 | FDA 483 | OCPP LLC - Form 483, 2019-09-04 |
| September, 2019 | EIR | OCPP LLC - EIR, 2019-09-04 |
| February, 2017 | FDA 483 | Louie Foods International - Form 483, 2017-02-28 |
| October, 2021 | FDA 483 | Pet Center Inc - Form 483, 2021-10-08 |
| May, 2021 | FDA 483 | OCPP LLC - Form 483, 2021-05-26 |
| July, 2021 | FDA 483 Response | Pet Center Inc - Form 483R, 2021-08-07 |
| July, 2021 | EIR | Pet Center Inc - EIR, 2021-07-13 |
| November, 2017 | FDA 483 | Olam West Coast Inc. - Form 483, 2017-11-21 |
| October, 2021 | EIR | Pet Center Inc - EIR, 2021-10-14 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more